×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.

Become an Incathlab member and receive full access to its content!

You must be an Incathlab member to access videos without any restrictions. Register for free in one minute and access all services provided by Incathlab.You will also be able to log into Incathlab from your Facebook or twitter account by clicking on login on the top-right corner of Incathlab website.

Registration Login


Worldwide schedules comment Share

This is a case-based discussion on how DynamX Bioadaptor improves patients' clinical outcomes in real life. Also the faculty will delve into the current unmet long-term needs in PCI with DES.

They will also discuss the 2 year findings of the Bioadaptor RCT trial and 1 year findings of INFINITY SWEDEHEART trial and provide their perspective on the clinical implications of these findings and potential impact on the future of PCI in light of the outcomes.

1-year outcomes from INFINITY-SWEDEHEART RCT recently presented at ESC 2024 demonstrated that DynamX Bioadaptor meets primary endpoint and significantly reduces adverse events compared to DES after 6 months.

Learn more about INFINITY-SWEDEHEART outcomes

Chairwoman
Rasha Al-Lamee, London, United Kingdom

Speakers
Johan Bennett, Leuven, Belgium
Davide Capodanno, Catania, Italy
David Erlinge, Lund, Sweden
Teguh Santoso, Jakarta, Indonesia

Agenda

Welcome, Clinical Rationale for Bioadaptive PCI
Rasha Al-Lamee
 
Overview of Latest Clinical Evidence:
  • INFINITY-SWEDEHEART RCT: David Erlinge
  • BIOADAPTOR RCT: Johan Bennett
Discussion: Clinical implications and lessons learned from multiple RCTs
Davide Capodanno
 
Case Presentations: Bioadaptor in practice
Teguh Santoso
 
Closing Remarks and Take-aways
Rasha Al-Lamee
 

 

 

Shooting date : 2024-09-18
Last update : 2024-10-04
1 comment
Join the Discussion
  • Bimlendu K. good idea for preservation of vascular remodelling and endothelial function

      Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
      Your browser doesn't have Flash, Silverlight or HTML5 support.


    Suggestions

    Wednesday, July 5th 2023 from 06pm to 07pm (GMT+2)
    Honolulu : Wednesday, July 5th 2023 from 07am to 08am (GMT+2)
    San Francisco : Wednesday, July 5th 2023 from 10am to 11am (GMT+2)
    New York : Wednesday, July 5th 2023 from 01pm to 02pm (GMT+2)
    Buenos Aires : Wednesday, July 5th 2023 from 02pm to 03pm (GMT+2)
    Reykjavik : Wednesday, July 5th 2023 from 05pm to 06pm (GMT+2)
    London / Dublin : Wednesday, July 5th 2023 from 06pm to 07pm (GMT+2)
    Paris / Berlin : Wednesday, July 5th 2023 from 07pm to 08pm (GMT+2)
    Istanbul : Wednesday, July 5th 2023 from 08pm to 09pm (GMT+2)
    Moscou / Dubaï : Wednesday, July 5th 2023 from 09pm to 10pm (GMT+2)
    Bangkok : Thursday, July 6th 2023 from 12am to 01am (GMT+2)
    Shanghai : Thursday, July 6th 2023 from 01am to 02am (GMT+2)
    Tokyo : Thursday, July 6th 2023 from 02am to 03am (GMT+2)
    Sydney : Thursday, July 6th 2023 from 04am to 05am (GMT+2)
    Wellington : Thursday, July 6th 2023 from 06am to 07am (GMT+2)

    Left Main and Bifurcation treatment:

    impact of clinical trials in daily practice

    Share
    Friday, March 28th 2025 from 08am to 10pm (GMT+1)
    Honolulu : Thursday, March 27th 2025 from 09pm to 11am (GMT+1)
    San Francisco : Thursday, March 27th 2025 from 11pm to 01pm (GMT+1)
    New York : Friday, March 28th 2025 from 02am to 04pm (GMT+1)
    Buenos Aires : Friday, March 28th 2025 from 04am to 06pm (GMT+1)
    London / Dublin : Friday, March 28th 2025 from 07am to 09pm (GMT+1)
    Paris / Berlin : Friday, March 28th 2025 from 08am to 10pm (GMT+1)
    Istanbul : Friday, March 28th 2025 from 09am to 11pm (GMT+1)
    Moscou / Dubaï : Friday, March 28th 2025 from 11am to 01am (GMT+1)
    Bangkok : Friday, March 28th 2025 from 02pm to 04am (GMT+1)
    Shanghai : Friday, March 28th 2025 from 03pm to 05am (GMT+1)
    Tokyo : Friday, March 28th 2025 from 04pm to 06am (GMT+1)
    Sydney : Friday, March 28th 2025 from 05pm to 07am (GMT+1)
    Wellington : Friday, March 28th 2025 from 07pm to 09am (GMT+1)

    Complex & High-Risk Indicated Procedures

    Discover the 6th edition - Day #1

    Share
    Wednesday, October 4th 2023 from 06pm to 06:45pm (GMT+2)
    Honolulu : Wednesday, October 4th 2023 from 07am to 07:45am (GMT+2)
    San Francisco : Wednesday, October 4th 2023 from 10am to 10:45am (GMT+2)
    New York : Wednesday, October 4th 2023 from 01pm to 01:45pm (GMT+2)
    Buenos Aires : Wednesday, October 4th 2023 from 02pm to 02:45pm (GMT+2)
    Reykjavik : Wednesday, October 4th 2023 from 05pm to 05:45pm (GMT+2)
    London / Dublin : Wednesday, October 4th 2023 from 06pm to 06:45pm (GMT+2)
    Paris / Berlin : Wednesday, October 4th 2023 from 07pm to 07:45pm (GMT+2)
    Istanbul : Wednesday, October 4th 2023 from 08pm to 08:45pm (GMT+2)
    Moscou / Dubaï : Wednesday, October 4th 2023 from 09pm to 09:45pm (GMT+2)
    Bangkok : Thursday, October 5th 2023 from 12am to 12:45am (GMT+2)
    Shanghai : Thursday, October 5th 2023 from 01am to 01:45am (GMT+2)
    Tokyo : Thursday, October 5th 2023 from 02am to 02:45am (GMT+2)
    Sydney : Thursday, October 5th 2023 from 04am to 04:45am (GMT+2)
    Wellington : Thursday, October 5th 2023 from 06am to 06:45am (GMT+2)

    Guides de 1ère intention :

    algorithme décisionnel de la lésion simple à la lésion complexe

    Share
    Tuesday, October 25th 2022 from 06pm to 07:15pm (GMT+2)
    Honolulu : Tuesday, October 25th 2022 from 07am to 08:15am (GMT+2)
    San Francisco : Tuesday, October 25th 2022 from 10am to 11:15am (GMT+2)
    New York : Tuesday, October 25th 2022 from 01pm to 02:15pm (GMT+2)
    Buenos Aires : Tuesday, October 25th 2022 from 02pm to 03:15pm (GMT+2)
    Reykjavik : Tuesday, October 25th 2022 from 05pm to 06:15pm (GMT+2)
    London / Dublin : Tuesday, October 25th 2022 from 06pm to 07:15pm (GMT+2)
    Paris / Berlin : Tuesday, October 25th 2022 from 07pm to 08:15pm (GMT+2)
    Istanbul : Tuesday, October 25th 2022 from 08pm to 09:15pm (GMT+2)
    Moscou / Dubaï : Tuesday, October 25th 2022 from 09pm to 10:15pm (GMT+2)
    Bangkok : Wednesday, October 26th 2022 from 12am to 01:15am (GMT+2)
    Shanghai : Wednesday, October 26th 2022 from 01am to 02:15am (GMT+2)
    Tokyo : Wednesday, October 26th 2022 from 02am to 03:15am (GMT+2)
    Sydney : Wednesday, October 26th 2022 from 04am to 05:15am (GMT+2)
    Wellington : Wednesday, October 26th 2022 from 06am to 07:15am (GMT+2)

    The role of hemodynamic support in cardiogenic shock:

    When to escalate and when to de-escalate

    Share
    Friday, February 17th 2023 from 12:30pm to 02pm (GMT+1)
    Honolulu : Friday, February 17th 2023 from 01:30am to 03am (GMT+1)
    San Francisco : Friday, February 17th 2023 from 03:30am to 05am (GMT+1)
    New York : Friday, February 17th 2023 from 06:30am to 08am (GMT+1)
    Buenos Aires : Friday, February 17th 2023 from 08:30am to 10am (GMT+1)
    London / Dublin : Friday, February 17th 2023 from 11:30am to 01pm (GMT+1)
    Paris / Berlin : Friday, February 17th 2023 from 12:30pm to 02pm (GMT+1)
    Istanbul : Friday, February 17th 2023 from 01:30pm to 03pm (GMT+1)
    Moscou / Dubaï : Friday, February 17th 2023 from 03:30pm to 05pm (GMT+1)
    Bangkok : Friday, February 17th 2023 from 06:30pm to 08pm (GMT+1)
    Shanghai : Friday, February 17th 2023 from 07:30pm to 09pm (GMT+1)
    Tokyo : Friday, February 17th 2023 from 08:30pm to 10pm (GMT+1)
    Sydney : Friday, February 17th 2023 from 09:30pm to 11pm (GMT+1)
    Wellington : Friday, February 17th 2023 from 11:30pm to 01am (GMT+1)

    Coronary sinus reducer

    Share
    Scroll Up